SCHEMBL4055692

SCHEMBL4055692

CCCC1CCC(c2ccc(C(=O)OC(C)(C)C)cc2)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.66
ALDH1A1 P00352 3/20 0.63
MAPT P10636 2/20 0.63
LMNA P02545 1/20 0.63
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
MAPK1 P28482 1/20 0.56
ESR2 Q92731 3/20 0.41
GPR119 Q8TDV5 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC1 Q13547 1/20 0.38
DGAT1 O75907 1/20 0.38
HDAC3 O15379 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4055689 1.00 CYP2C9 (0.66) CYP2C9ALDH1A1MAPTLMNAKMT2A
SCHEMBL20437077 0.88 CA12 (0.47) CYP2C9ALDH1A1MAPTLMNAESR2
SCHEMBL20046737 0.87 ESR2 (0.51) CYP2C9ALDH1A1MAPTLMNAKMT2A
SCHEMBL11041282 0.86 ALDH1A1 (0.70) CYP2C9ALDH1A1MAPTLMNAKMT2A
SCHEMBL11041289 0.86 ALDH1A1 (0.70) CYP2C9ALDH1A1MAPTLMNAKMT2A
SCHEMBL9649132 0.83 CYP2C9 (0.66) CYP2C9ALDH1A1MAPTLMNAKMT2A
SCHEMBL10938649 0.83 CYP2C9 (0.66) CYP2C9ALDH1A1MAPTLMNAKMT2A
SCHEMBL9649144 0.83 CYP2C9 (0.66) CYP2C9ALDH1A1MAPTLMNAKMT2A
SCHEMBL11037755 0.83 CYP2C9 (0.66) CYP2C9ALDH1A1MAPTLMNAKMT2A
SCHEMBL9649129 0.83 CYP2C9 (0.66) CYP2C9ALDH1A1MAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
US-7534547-B2 Optically active compound and photosensitive resin composition OSAKA GAS COMPANY LIMITED (JP) 2009-05-19 US disclosed
EP-1375463-A1 OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION Kansai Research Institute, Inc. (JP) 2004-01-02 EP disclosed
US-20030211421-A1 Optically active compound and photosensitive resin composition KRI, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030211421-A1 Optically active compound and photosensitive resin composition ARCN1, RAD51, PAM CYP2C9 1479/4885ALDH1A1 1552/4885MAPT 3954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.